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Structural biologyRv2140c is one of many conserved Mycobacterium tuberculosis proteins for which no molecular
function has been identiﬁed. We have determined a high-resolution crystal structure of the
Rv2140c gene product, which reveals a dimeric complex that shares strong structural homology
with the phosphatidylethanolamine-binding family of proteins. Rv2140c forms low-millimolar
interactions with a selection of soluble phosphatidylethanolamine analogs, indicating that it has
a role in lipid metabolism. Furthermore, the small molecule locostatin binds to the Rv2140c
ligand-binding site and also inhibits the growth of the model organism Mycobacterium smegmatis.
Structured digital abstract:
Rv2140c and Rv2140c bind by molecular sieving (View interaction)
Rv2140c and Rv2140c bind by cosedimentation in solution (View interaction)
Rv2140c and Rv2140c bind by x-ray crystallography (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Here, we show that the Mtb annotated hypothetical proteinThe Mycobacterium tuberculosis (Mtb) Rv2140c open reading
frame is annotated to encode a conserved hypothetical protein
[1]. Quantitative RT-PCR experiments show marked changes in
the level of Rv2140c expression when Mtb is grown in inter-
feron-c-activated macrophages compared with non-activated
macrophages [2], indicating that Rv2140c may contribute towards
a self-protection mechanism within the host phagolysosomal envi-
ronment. Furthermore, disruption of the Rv2140c gene results in
the attenuation of Mtb growth in mouse models [3]. Rv2140c also
strongly stimulates the release of interferon-c in Mtb-infected
mice, suggesting that the protein could represent a new candidate
for either a protective vaccine [4,5] or a diagnostic reagent [6].Rv2140c in fact belongs to the phosphatidylethanolamine-binding
protein (PEBP) family. The ﬁrst PEBP described was a cytosolic
23 kDa protein that was isolated from bovine brain material and
subsequently shown to bind phosphatidylethanolamine (PE), an
important polar lipid component in many cell membranes [7,8].
PEBPs are relatively small proteins that normally comprise about
200 amino acids. They adopt a tight globular fold with a conserved
pocket that binds a range of phospho-compounds, including phos-
phorylethanolamine, phosphate and phosphotyrosine [9–12].
In addition to identifying Rv2140c fromM. tuberculosis as a new
PEBP family member, we have investigated its interactions with PE
analogs and locostatin. These are the ﬁrst ligand-binding studies
for a bacterial PEBP. A Mycobacterium smegmatis strain lacking
the Rv2140c homologous gene was also genetically engineered to
characterize the impact of both Rv2140c and locostatin in a Mtb
model system.
2. Materials and methods
2.1. Cloning, expression, puriﬁcation and crystallization
Rv2140c-pETM-11 was expressed in Bl21(DE3) pLysS cells fol-
lowing overnight auto-induction at 18 C [13]. Cell pellets, resus-
pended in 50 mM HEPES pH 8.0, 300 mM NaCl, 20 mM imidazole,
Table 1
Crystallographic statistics.
Native Ligand-bound
Data collection
Space group C2221 P41212
Cell dimensions a, b, c [Å] 63.2, 82.6 126.1 62.1, 62.1, 181.7
Wavelength [Å] 0.93 0.84
Overall resolution range [Å] 63.0–1.70 27.2–1.42
Highest resolution range [Å] 1.79–1.70 1.50–1.42
Number of unique reﬂections 37023 67658
Multiplicity 3.7 (3.4) 5.9 (5.2)
Mean I/r(I) 6.1 (2.3) 18.0 (2.5)
Completeness (%) 98.4 (95.7) 99.5 (97.5)
Rsym
a 5.5 (36.0) 2.9 (31.0)
Reﬁnement
Protein atoms 2651 2651
Other atoms 332 water 399 water, 2 sulfate
ions, 6 glycerol
Rconv
b/Rfreec 17.4/20.5 15.1/19.5
Rms deviations
Bond lengths (Å) 0.011 0.021
Bond angles () 1.320 2.02
a Rsym ¼
P
h
P
jjIh;j  hIhij=
P
h
P
jIh;j where Ih,j is the intensity of the jth observa-
tion of unique reﬂection h.
b P
hjjFohj  jFchjj=
P
hjFohj where Foh and Fch are the observed and calculated
structure factor amplitudes for reﬂection h.
c Rfree is equivalent to Rconv, but is calculated using a 5% disjoint set of reﬂections
excluded from the maximum likelihood reﬁnement stages.
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DNaseI treatment and sonication. Rv2140c was puriﬁed from the
soluble cellular fraction by Ni–NTA afﬁnity chromatography, fol-
lowed by digestion with TEV protease and a ﬁnal size exclusion
chromatography step (Pharmacia Superdex 200 HiLoad 26/60) in
40 mM HEPES pH 8.0, 0.02% MTG. Apo Rv2140c crystals were
grown at 22 C using the hanging-drop method by mixing equal
volumes (1 ll) of Rv2140c (15 mg/ml) and well solution
(100 mM sodium acetate trihydrate pH 4.6, 220 mM calcium chlo-
ride dihydrate, 23% v/v 2-propanol). Ligand-bound crystals were
grown from 0.1 M Tris pH 8.0, 2.4 M ammonium sulfate solution.
2.2. X-ray structure determination of Mtb Rv2140c
Prior to data collection at 100 K, apo Rv2140c crystals were
cryo-protected in mother liquor containing 30% glycerol. The
apo-Rv2140c dataset, collected at the ESRF beamline BM14, and
the sulfate-bound dataset, collected at DESY, beamline BW7B, were
integrated using the program XDS and then scaled and merged
with SCALA [14,15]. The structure of Rv2140c was solved by
molecular replacement with the program Phaser [16]. The Esche-
richia coli YBHB monomer structure, modiﬁed to create a hybrid
structure by trimming back to Cb residues not conserved between
the two proteins, was used as the search model (PDB code 1FJJ)
[17]. COOT was used for manual rebuilding alternating with reﬁne-
ment using REFMAC5 [14,18]. Statistics for the ﬁnal model are gi-
ven in Table 1. Coordinates/structure factors have been submitted
to the PDB database with the accession codes 4BEF and 4BEG.
2.3. Isothermal titration calorimetry (ITC)
Triplicate ITC experiments with Rv2140c and phospholipids
(Avanti Polar Lipids) were performed with a VP-ITC (MicroCal) in
50 mM NaCl, 20 mM NaH2PO4 pH 6.5 at 25 C. Data analysis and
curve ﬁtting were performed with Origin 7 and the MicroCal
plug-in for a standard non-interacting one-site model. Due to the
low afﬁnity of the interaction, the inﬂection point of the curve
becomes poorly deﬁned. The stoichiometry parameter N wastherefore ﬁxed to 1.0 for all the ﬁttings [19], consistent with our
structural information and other published data [20].
2.4. Expression of labeled Mtb Rv2140c for NMR studies
Rv2140c was cloned into the pTriEX-4 EK/LIC (Novagen) vector.
Expression of isotopically labeled Rv2140c in Bl21 (DE3) on M9
medium supplemented with 60 lg/l carbenicillin and 0.5 g/l
[15N]-NH4Cl and 2 g/l natural abundance glucose for [15N]-labeling
or 2 g/l [13C]-glucose for [15N,13C]-labeling was induced with 1 mM
IPTG for 5 h at 37 C. Cell pellets, resuspended in 20 mM Tris/HCl
(pH 7.4), 500 mM NaCl, 5 mM imidazole, 1 tablet Complete
EDTA-free Protease Inhibitors (Roche), 5 mMMgSO4 and 10 ll Ben-
zonase (Novagen), were lysed using a French Press. Rv2140c was
puriﬁed from the soluble cellular fraction on Ni-Poros MC20 mate-
rial (Applied Biosystems), digested by Enterokinase (Novagen), fol-
lowed by a second round of metal chelating chromatography on
Ni-Poros and buffer-exchange into 20 mM Na phosphate buffer
pH 7.0, 50 mM NaCl, 0.02% azide.
2.5. NMR spectroscopy
NMR experiments were recorded using Bruker DRX600,
DMX750 and AV900 spectrometers at 300 K with triple resonance
cryogenic probes. The backbone assignment was conducted using
the CCPNmr Analysis software [21] and standard HNCA, HN(CO)CA,
HNCO and HN(CA)CO experiments recorded at 750 MHz and
CBCANH and CBCA(CO)NH experiments recorded at 900 MHz.
Chemical shifts have been deposited in the Biological Magnetic
Resonance Data Bank (BMRB) under accession code 19088. The
titration with locostatin was performed at 600 MHz using a
0.1 mM 15N-labeled Rv2140c sample and concentrated stock solu-
tions (20, 50 and 100 mM) of locostatin in methanol. After each
addition of locostatin, a HSQC spectrum was recorded. A reference
spectrum of Rv2140c with 3% methanol showed that the chemical
shift changes observed during the titration were induced by the
locostatin and not by the methanol. Chemical shift distances were
measured using a scaling factor of 0.15 for the 15N chemical shifts
and the Origin software package was used to ﬁt the data to obtain
an approximate Kd value.
2.6. Creation of M. smegmatis knockout strain
The M. smegmatis DMSMEG_4199 strain was generated by
deleting the MSMEG_4199 gene with a recombineering method
(Suppl. method 1) [22].
2.7. Characterization of a M. smegmatis DMSMEG_4199 gene knock-
out strain
M. smegmatis cultures grown at 37 C were washed three times
in 7H9 broth and diluted to an OD600 of 0.5. 500 ll of 7H9 broth
were inoculated with 50 ll of diluted culture. The growth of M.
smegmatis wt and DMSMEG_4199 strains in the presence and ab-
sence of locostatin (dissolved in DMSO) was then monitored with
a TECAN Inﬁnite M1000 plate reader. Triplicate growth experi-
ments at 37 C were performed in the presence of a ﬁnal concen-
tration of 0.1% (v/v) DMSOwith orbital shaking of 4 mm amplitude.3. Results and discussion
3.1. Rv2140c encodes a new member of the PEBP family
The M. tuberculosis open reading frame Rv2140c, annotated to
encode a conserved 18.6 kDa hypothetical protein [23], has
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mycobacterial genomes (Suppl. Figs. 1 and 2). A sequence compar-
ison indicates that Rv2140c could be a member of the PEBP family
as it shares moderate levels of sequence identity with other PEBPs;
the closest non-mycobacterial sequence is the E. coli YBHB protein
with 46% identity. This hypothesis is further supported by the pres-
ence of the characteristic conserved region 1 (CR1) and CR2 se-
quence motifs (Suppl. Fig. 2).
3.2. X-ray structure of Rv2140c
The 1.70 Å X-ray crystal structure of Rv2140c (Table 1, Fig. 1)
reveals an intimate head-to-tail dimer with an interface area of
1044 Å2 [24]. A dimeric assembly is consistent with size-exclusion
chromatography data and analytical ultracentrifugation data (Sup-
pl. Fig. 3). Each Rv2140c molecule comprises a globular fold dom-
inated by a central ﬁve-stranded anti-parallel beta sheet (b3, b4,
b6, b7 and b8). This sheet is ﬂanked on one side by a second smaller
beta sheet formed from beta strands (b1, b2 and b5) and on the
other side by an alpha helix (a3). This general topology is shared
by all structures from the PEBP family that have been determined
to date (Suppl. Table S1).
A second crystal structure revealed a sulfate ion, originating
from the crystallization mother liquor, bound to the Rv2140c li-
gand-binding site (Fig. 1B, Table 1). Given the structural and chem-
ical similarity of phosphate and sulfate ions, we assume that this is
also the binding site for phospho-compounds predicted to bind to
Rv2140c. The protein accommodates the potential ligand mimic
without any signiﬁcant conformational rearrangements, as shown
by a low root mean squares deviation (r.m.s.d.) of 0.25 Å over all
equivalent residues of the superimposed apo and sulfate-boundβ1
α1
β2
β3
β4β5
α2
β6
β7
α3
β8
(A)
E148
Ligand-binding site
Ligand-binding site
R100
E148
Fig. 1. X-ray crystal structure of Rv2140c (A) Cartoon representation of the Rv2140c dime
and loops are colored purple, blue and yellow, respectively) and the second protomer i
sulfate ion within the Rv2140c ligand-binding site. Key interacting residues are shown i
respectively. Hydrogen-bond interactions between the sulfate ion and the protein are sh
model-phased 2Fobs  Fcalcacalc electron density contoured at 0.2 e A3 is shown in lighstructures. In each Rv2140c protomer, a single sulfate ion forms
hydrogen bonds with Asp68, His79, Ala122, His130 and Tyr132.
The location of the sulfate ion within the Rv2140c ligand-binding
site is similar to that observed for the PE-phosphate group and re-
lated anions/anionic compounds bound to other PEBPs (Suppl.
Fig. 4) [9–12].
3.3. Comparison between Rv2140c and other structures
Tertiary structure similarity searches of the PDB database using
PDBeFold [25] conﬁrmed our hypothesis that Rv2140c shares sig-
niﬁcant structural homology with the PEBP family of proteins
(Suppl. Table S1). The closest structural homolog is the E. coli YBHB
protein [17]. The two structures share an r.m.s.d. of 1.1 Å over
155 equiv Ca residues (Suppl. Table S1). The core fold and the
dimeric assembly of the E. coli and Mtb proteins are structurally
conserved (Fig. 2). Compared with YBHB, Rv2140c has a 16-residue
N-terminal extension that folds loosely across the surface of the
protein (Fig. 2B). An N-terminal sequence extension is also present
in some other bacterial PEBPs although the sequence homology in
this region is generally low (Suppl. Fig. 2). Additionally, surface
loops 1 and 2 adopt different conformations in the two proteins
(Fig. 2A/C). As these loops have a virtually identical conformation
in the apo and ligand-bound conformation of the Mtb protein,
the differences observed are probably due to diverging sequences.
Indeed, in these regions the sequence conservation between the
two proteins is low compared with residues located either in the
core of the protein, the dimeric interface or at the core of the li-
gand-binding site (Suppl. Figs. 2 and 5). Two of these loop devia-
tions (residues 36–41 and 124–130) ﬂank the sulfate-binding site
(Fig. 2C).(B)
R100
F77
H79
A71
H130
P124
D68
A122
r. One protomer is colored according to secondary structure content (helices, sheets
s colored green with its molecular surface rendered in gray. (B) Binding mode of a
n stick representation with C, N, O and S atoms colored green, blue, red and yellow
own (gray dotted line). Solvent molecules are shown as red spheres. Representative
t blue.
(A) C’
N’
N’
C’
(B)
H79
D68Y132
F77
F157* P72
H130
P124
Loop1
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(C)
α3
Fig. 2. Comparison of M. tuberculosis Rv2140c and E. coli PEBP structures (A) Superposition of Rv2140c (cyan/pink) with the E. coli YBHB PEBP structure (yellow) [17]. The
Rv2140c N-terminal extension that is not found in YBHB is colored dark blue and red in the respective chains. A sulfate molecule, observed binding at one of the Rv2140c
ligand-binding sites, is shown in stick/surface representation. (B) Molecules are colored as in (A) with the exception that the surface is shown for Rv2140c cyan molecule,
residues 17–176. The Rv2140c N-terminal extension can be seen folding loosely across the protein surface. It is completely resolved in the electron density and does not
interact with the ligand-binding site. View is rotated 180 about the x-axis to that seen in (A). (C) Detailed comparison of the ligand-binding sites in the two proteins. In
particular, the different conformations of the adjacent two loops inﬂuence the peripheral surface properties of the two binding sites. The binding site is predominantly formed
from residues from one protomer. Phe157⁄, originating from the dimeric partner, also contributes towards the formation of the binding site. Residues surrounding the sulfate
molecule are shown in stick representation with C, N, O and S atoms colored yellow/cyan/pink, blue, red or yellow, respectively.
Fig. 3. Isothermal colorimetric characterization of the Rv2140c interactions with DHPE, DHPG and DHPS ITC binding curve for the interaction of DHPE, DHPS and DHPG with
Rv2140c. The top panel shows the raw ITC binding data. In the bottom panels the integrated heat change per injection is shown (square data points). Molar ratio is deﬁned as
the ratio of PE-analog concentration to Rv2140c protein concentration. The corresponding reference curves in which DHPE, DHPS and DHPG were injected into buffer are also
shown (circles).
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PE-binding protein
To validate our hypothesis that Rv2140c is a PEBP, we carried
out ITC experiments to measure PE binding (Fig. 3). As the solubil-
ity of PE is too low for such experiments, we used the short-chain
PE analogs dihexanoyl phosphoethanolamine (DHPE), dihexanoyl
phosphatidylglycerol (DHPG) and dihexanoyl phosphatidylserine
(DHPS) [20]. Rv2140c indeed binds these PE analogs, with dissoci-
ation constants of approximately 1 mM (Fig. 3, Table 2). These are
the ﬁrst ligand-binding studies for a bacterial PEBP and interest-
ingly show that the Rv2140c dissociation constants are of a similar
order of magnitude to those reported for PE and a rat PEBP, Raf-1
kinase inhibitory protein (RKIP) [20].
3.5. The inhibitor locostatin binds to the Rv2140c ligand-binding site
Following reports that the small molecule 4-benzyl-3-croto-
nyl-2-oxazolidinone (Suppl. Fig. 6) – known as ‘‘locostatin’’ – isTable 2
Isothermal calorimetric characterization of the Rv2140c interactions with PE-analogs.
DHPE DHPS DHPG
Kd (mM) 2.31 ± 0.05 1.35 ± 0.07 1.15 ± 0.03
DG (kcal/mol) 3.60 ± 0.01 3.94 ± 0.07 4.01 ± 0.02
DH (kcal/mol) 4.99 ± 0.14 7.62 ± 0.55 6.59 ± 0.47
TDS (kcal/mol) 1.40 ± 0.14 3.68 ± 0.62 2.58 ± 0.49
Derived dissociation constants and thermodynamic parameters for DHPE, DHPS and
DHPG. Values and standard deviations are calculated from triplicate experiments.
ITC binding curves and the integrated heat change per injection for these interac-
tions are shown in Fig. 3.
(A)
(B)
F157
F77
M39
I38
A121
F157
Fig. 4. NMR-based localization of the locostatin-binding site (A) 1H–15N HSQC spectru
600 MHz and a temperature of 300 K. Assignments are shown for the resonances with t
shifts onto the Rv2140c–sulfate complex X-ray structure. The two protomers are colored
the addition of locostatin are colored red (> 0.10 ppm), orange (>=0.04 & <0.10 ppm) and
representation, with oxygen and sulfur atoms colored red and yellow, respectively. Detaa human RKIP inhibitor, we investigated whether locostatin also
interacts with Rv2140c [26]. Although we could qualitatively ob-
serve an interaction between the two binding partners using ITC,
it was not possible to obtain statistically relevant data, probably
because of the relatively low interaction afﬁnity and limited
aqueous solubility of locostatin. We therefore performed NMR-
based titrations in which protein heteronuclear single quantum
coherence (HSQC) peaks were used as site-speciﬁc probes for
locostatin binding. The inhibitor indeed speciﬁcally binds to
Rv2140c in physiological buffered conditions (Fig. 4A, Suppl.
Fig. 7) and the most signiﬁcantly shifted peaks correspond to
the residues Ile38, Met39, Ala41, Thr73, Gly76, Phe77, Trp78,
Val119, Ala121, Ala122, Phe157 and Leu159. These amino acids
are clustered at a common surface of Rv2140c, which matches
the Rv2140c sulfate-binding site (Fig. 4B). Furthermore, NMR
titrations with locostatin indicate that it binds with an apparent
Kd of approximately 1.0 ± 0.2 mM. Unfortunately, attempts to
solve an X-ray structure of Rv2140c in the presence of locostatin
failed.
3.6. Inﬂuence of locostatin on M. smegmatis growth
To characterize whether binding of locostatin to Rv2140c trans-
lates into an in vivo phenotype we used the less pathogenic M.
smegmatis, which is a widely established model system for Mtb.
TheM. smegmatisMSMEG_4199 gene encodes a protein that shares
76% sequence identity with Rv2140c, suggesting that its structural
and functional properties are related (Suppl. Fig. 1). We engineered
a MSMEG_4199 knock-out M. smegmatis strain (DMSMEG_4199)
(Suppl. Fig. 8) and measured its growth compared to wild-typeF77F157
M39
W78
A121
V119
I38
m of Rv2140c without (blue) and with (red) locostatin (1:10 M ratio) recorded at
he largest chemical shift changes. (B) Mapping of the locostatin-dependent residue
light and dark gray, respectively. Residues observed to undergo chemical shifts upon
yellow <=0.03 & >0.04 ppm), respectively. The bound sulfate ion is shown in stick
ils of all observed chemical shifts can be found in Suppl. Fig. 7.
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Fig. 5. Characterization of a M. smegmatis DMSMEG_4199 gene knock-out strain
Growth of bothDMSMEG_4199 and wtM. smegmatis in the presence and absence of
200 lM locostatin. In the absence of locostatin both wt (dark blue) and
DMSMEG_4199 (red) strains grew at the same rate. In the presence of 200 lM
locostatin growth of both wt (magenta) and DMSMEG_4199 (light blue) M.
smegmatis was delayed.
G. Eulenburg et al. / FEBS Letters 587 (2013) 2936–2942 2941(wt) in the presence and absence of locostatin (Fig. 5). In the ab-
sence of locostatin, both M. smegmatis strains grew at the same
rate, indicating that MSMEG_4199 is not essential under the condi-
tions tested. This observation is consistent with previous ﬁndings
that Rv2140c is not essential in Mtb in vivo [27,28]. By contrast,
the growth rates of wt and DMSMEG_4199 strains were both sig-
niﬁcantly delayed by a similar order of magnitude when the myco-
bacteria were cultured in the presence of 200 lM locostatin
(Fig. 5). These data indicate that locostatin inhibits additional tar-
gets, in addition to MSMEG_4199, which have not yet been identi-
ﬁed. Given that the binding afﬁnity of locostatin to the Mtb
homolog is in the low mM range, it is likely that the potential
inhibitory effect of locostatin on Rv2140c is overshadowed by
greater effects on other targets.
As with other PEBPs reported in the literature, the biological
function of Rv2140c remains elusive. The data presented in this
contribution provide a starting point from which these open func-
tional questions can be addressed.
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